Even though the Biden administration removed some of the restrictions on medical professionals' ability to give buprenorphine, there is much to learn still from the geographic distribution of the waivers. Buprenorphine is used to treat opioid use disorder. In order to prescribe it, however, professionals are required to take training and apply for a waiver. That requirement was set to be removed in January 2021, but President Biden withdrew that option. Dr. Brady and Ms. Koch will share the data regarding the geographic distribution of the providers' waivers and discuss best practice policies for the future in opioid use disorder.